|
|
Eli Lilly agrees to buy ImClone for over $6B
NEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.
Nations:U.S. People:Carl Icahn Source:(AP)
2008-10-06
Study: New way to spot breast cancer shows promise
A radioactive tracer that "lights up" cancer hiding inside dense breasts showed promise in its first big test against mammograms, revealing more tumors and giving fewer false alarms, doctors reported Wednesday.
Source:(AP)
2008-09-03
Stocks tumble after sales of existing homes fall
NEW YORK - Wall Street abruptly ended an earnings-driven rally and closed sharply lower Thursday after a steeper-than-expected decline in existing home sales and worries about the financial sector chilled the market's recent optimism. The major indexes fell about 2 percent, including the Dow Jones industrial average, which lost more than 280 points.
Nations:Germany Japan France Activities:U.S. Markets Source:(AP)
2008-07-24
Bristol-Myers settles Clean Air violations
INDIANAPOLIS - Pharmaceuticals maker Bristol-Myers Squibb Co. has agreed to spend $3.65 million to resolve federal Clean Air Act violations by eliminating ozone-depleting refrigerants at factories in six states and Puerto Rico.
Nations:U.S. Source:(AP)
2008-07-09
Lilly drug reduces stent clot risks, study finds
Patients who got Eli Lilly and Co's anti-clotting drug prasugrel after a coronary stent procedure had fewer stent-related clots than those on standard drug therapy, an analysis released on Saturday found.
2008-03-29
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|